Vera Therapeutics (VERA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting commenced at 8:00 A.M. Pacific Time on May 21st, 2026, via a virtual platform, with board members, executive team, and auditors present.
The agenda included three proposals: election of directors, ratification of auditors, and an advisory vote on executive compensation.
Voting procedures and rules of conduct were explained, with polls open for all matters.
Board and executive committee updates
Three nominees for Class II directors were presented: Michael Morrissey, Patrick Enright, and James Myers, to serve until the 2029 annual meeting.
Shareholder proposals
Three proposals were submitted: election of directors, ratification of KPMG LLP as auditors for 2026, and an advisory vote on executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Vera Therapeutics
- Atacicept nears pivotal data and broad expansion, targeting multiple autoimmune diseases.VERA
R&D Day 20249 Jul 2026 - Atacicept stabilized kidney function in IgA nephropathy; phase 3 data expected Q2 2025.VERA
7th Annual Evercore ISI HealthCONx Conference9 Jul 2026 - Atakicept shows strong efficacy and safety in IgAN, with launch and pipeline expansion imminent.VERA
Citi Annual Global Healthcare Conference 20258 Jul 2026 - Atacicept achieved a 46% proteinuria reduction and strong safety in phase III IgAN trial.VERA
Study Result8 Jul 2026 - FDA accelerated approval for TRUTAKNA introduces a novel therapy for adults with IgA nephropathy.VERA
FDA announcement7 Jul 2026 - TRUTAKNA delivers robust efficacy and safety in IgAN, targeting a major unmet market need.VERA
Corporate presentation7 Jul 2026 - Atacicept advanced toward FDA approval as net loss widened to $121M, with strong cash reserves.VERA
Q1 20268 May 2026 - Atacicept nears FDA approval with strong data, broad label, and robust commercial launch plans.VERA
TD Cowen 46th Annual Health Care Conference1 May 2026 - Director elections, auditor ratification, and executive pay are key 2026 meeting agenda items.VERA
Proxy filing9 Apr 2026